Rachel A. Mcgovern
St Paul's Hospital
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.
Journal: Antiviral therapy
Published: October 15, 2014
Early immune adaptation in HIV-1 revealed by population-level approaches.
Journal: Retrovirology
Published: May 30, 2014
Temporal trends in the discontinuation of first-line antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy
Published: April 18, 2014
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint.
Journal: The Journal of antimicrobial chemotherapy
Published: May 17, 2013
Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing.
Journal: Journal of clinical microbiology
Published: November 24, 2012
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: October 26, 2012
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
Journal: Journal of virology
Published: April 13, 2012
Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.
Journal: Antimicrobial agents and chemotherapy
Published: December 07, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026